Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Kidney & Renal Pelvis (Late Stage^), 2013-2017

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Rate
State
 sort alphabetically by name ascending
Met Healthy People Objective of ***?
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate ascending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 *** 4.8 (4.8, 4.9) 18,219 29.1
Louisiana 3 *** 6.1 (5.8, 6.4) 327 28.2
Iowa 3 *** 6.1 (5.7, 6.5) 236 33.3
Kentucky 3 *** 6.0 (5.7, 6.3) 315 28.9
Mississippi 6 *** 5.8 (5.5, 6.2) 203 27.5
West Virginia 6 *** 5.7 (5.2, 6.1) 141 28.9
Nebraska 6 *** 5.6 (5.2, 6.1) 124 32.4
Arkansas 6 *** 5.6 (5.3, 6.0) 203 28.6
South Dakota 6 *** 5.6 (4.9, 6.3) 58 33.1
Oklahoma 6 *** 5.6 (5.3, 5.9) 252 29.0
Wisconsin 6 *** 5.6 (5.3, 5.8) 397 30.6
Indiana 6 *** 5.6 (5.3, 5.8) 425 29.5
Missouri 6 *** 5.5 (5.3, 5.8) 410 29.5
Texas 6 *** 5.4 (5.3, 5.5) 1,483 28.7
Illinois 6 *** 5.4 (5.2, 5.6) 800 30.2
North Dakota 6 *** 5.4 (4.7, 6.2) 45 32.0
Alaska 6 *** 5.3 (4.5, 6.2) 37 29.0
Ohio 6 *** 5.3 (5.1, 5.5) 761 30.9
Kansas 6 *** 5.3 (4.9, 5.6) 177 28.7
Minnesota 6 *** 5.1 (4.9, 5.4) 332 30.3
New Mexico 3 *** 5.1 (4.7, 5.5) 127 34.9
Montana 6 *** 5.1 (4.6, 5.7) 69 31.3
Rhode Island 6 *** 5.1 (4.5, 5.7) 66 31.2
Georgia 3 *** 5.1 (4.9, 5.3) 547 29.5
Tennessee 6 *** 5.0 (4.8, 5.3) 403 27.5
Connecticut 3 *** 4.9 (4.6, 5.2) 219 30.8
Pennsylvania 6 *** 4.9 (4.7, 5.1) 811 28.2
Maine 6 *** 4.9 (4.4, 5.3) 93 30.2
South Carolina 6 *** 4.8 (4.6, 5.1) 292 27.6
Idaho 3 *** 4.8 (4.3, 5.3) 90 28.8
Michigan 5 *** 4.8 # (4.6, 4.9) 587 29.4
Wyoming 6 *** 4.7 (4.0, 5.6) 32 34.4
New Hampshire 6 *** 4.7 (4.3, 5.2) 82 30.6
North Carolina 6 *** 4.7 (4.5, 4.9) 557 27.3
Washington 5 *** 4.7 (4.5, 4.9) 387 30.6
Vermont 6 *** 4.6 (4.0, 5.3) 39 33.5
New York 3 *** 4.6 (4.5, 4.7) 1,078 27.8
New Jersey 3 *** 4.6 (4.4, 4.8) 491 28.3
Delaware 6 *** 4.5 (4.0, 5.1) 55 27.1
Alabama 6 *** 4.5 (4.2, 4.7) 264 25.4
Massachusetts 3 *** 4.4 (4.2, 4.6) 367 28.3
Arizona 6 *** 4.4 (4.2, 4.6) 360 28.1
Hawaii 3 *** 4.4 (4.0, 4.9) 79 33.7
California 3 *** 4.4 (4.3, 4.5) 1,848 30.0
Oregon 6 *** 4.3 (4.0, 4.6) 216 27.7
Utah 3 *** 4.2 (3.9, 4.6) 110 30.6
Florida 6 *** 4.2 (4.1, 4.3) 1,155 29.2
Maryland 6 *** 4.1 (3.9, 4.4) 283 27.2
Virginia 6 *** 4.1 (3.9, 4.3) 392 26.4
Colorado 6 *** 4.1 (3.8, 4.3) 239 29.4
Nevada 6 *** 3.9 (3.6, 4.2) 129 27.2
District of Columbia 6 *** 3.5 (2.9, 4.2) 24 27.4
Puerto Rico 6 *** 2.1 (1.9, 2.3) 95 25.1
Notes:
Created by statecancerprofiles.cancer.gov on 07/12/2020 6:54 pm.

*** No Healthy People 2020 Objective for this cancer.

State Cancer Registries may provide more current or more local data.
† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The 1969-2017 US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Coding is generally based on Surveillance, Epidemiology, and End Results (SEER) summary stage but may include other staging variables if necessary.
Healthy People 2020 Objectives provided by the Centers for Disease Control and Prevention.

Health Service Areas are a single county or cluster of contiguous counties which are relatively self-contained with respect to hospital care. For more detailed information, please see Health Service Area information page.
# Data do not include cases diagnosed in other states for those states in which the data exchange agreement specifically prohibits the release of data to third parties.

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2017) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2019 submission.
3 Source: SEER November 2019 submission. State Cancer Registry also receives funding from CDC's National Program of Cancer Registries.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database (2001-2017) - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2019 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database (2001-2017) - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2019 submission).

Please note that the data comes from different sources. Due to different years of data availablility, most of the trends are AAPCs based on APCs but some are APCs calculated in SEER*Stat. Please refer to the source for each graph for additional information.

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data for United States does not include Puerto Rico.

Return to Top